Hyperhaemolysis syndrome (sickle cell)
Haemolysis · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A severe delayed transfusion reaction in sickle cell disease where both transfused and native red cells are destroyed, worsening anaemia despite (and because of) transfusion.
Figures & algorithms
Red flags
- Haemoglobin below pre-transfusion level
- Life-threatening anaemia
- Organ dysfunction
- Continued transfusion worsening the picture
Assessment
Differential diagnosis
- Delayed haemolytic transfusion reaction
- Acute sickle haemolytic crisis
- Aplastic crisis
- Autoimmune haemolytic anaemia
- Sequestration crisis
Investigations
- FBC and reticulocytes (may be low)
- Haemolysis screen (LDH, bilirubin, haptoglobin)
- Direct antiglobulin test and antibody screen
- Haemoglobin lower than pre-transfusion
- Urinalysis for haemoglobinuria
Management
- Recognise falling haemoglobin after transfusion
- Stop further transfusion unless life-threatening (it worsens haemolysis)
- Urgent haematology involvement
- Give IVIG and corticosteroids
- Supportive care and organ protection
- Consider further immunomodulation (specialist)
Drugs & doses
IVIG
Corticosteroids
Erythropoietin (specialist)
Avoid transfusion unless critical
Disposition
Critical care; urgent haematology.
Complications & pitfalls
- Life-threatening anaemia
- Multiorgan injury
- Death
Exam pearls
- A key clue is post-transfusion haemoglobin lower than before transfusion.
- Avoiding further transfusion is often the crucial step.
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.
